Guangzhou University of Traditional Chinese Medicine
Phase
Observational
Started
2022-06-06
Last updated
2022-11-15
Condition(s) studied
Chronic DiseaseCancerDementia AlzheimersMetabolic DiseaseAgingAlzheimer Disease, Early Onset
Investigational drug(s) / intervention(s)
natural aging process
natural aging process: To observe the relationship between new cases of diseases and health status of people exposed to different factors such as life style, alcohol consumption, eating habits, etc.
Study summary
The researchers plain to build a large-scale, longitudinal, prospective cohort characterized by TCM dampness syndrome. With the biobank of this cohort the investigators want to find the causality between TCM dampness syndrome and clinical chronic diseases and a new way to treat clinical disease.
Eligibility
Sex
ALL
Min age
35 Years
Max age
79 Years
Healthy volunteers
Accepted
Inclusion Criteria:
1. Residents aged 30 to 79, whose residence is consistent with their registered permanent residence location;
2. Residents who voluntarily participate in the project, agree to the collection of their biological information, and sign the informed consent form;
3. Residents who have no mental illness and other related diseases, and display a normal ability of expression and understanding;
Exclusion Criteria:
1. Residents who reject collaboration;
2. Residents who allow no follow-up visits.
Primary outcome measure(s)
emerging diseases — through study completion, an average of 1 year This study will pay attention to the emerging situation of clinical chronic diseases, such as cancer, diabetes, hypertension, coronary heart disease, dementia, etc. Each follow-up the researchers will record the incidence of the emerging diseases of interviewees' by questionnaire including the name of the disease, time of onset and treatments.
Trial sites (1)
Facility
City
Region
Status
Guangdong Province Hospital of Tradtional Chinese Medicine
Guangzhou
Guangdong
Recruiting
More Guangzhou University of Traditional Chinese Medicine trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.